Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies

NCT06208878 is registered in ClinicalTrials.gov with CRISPR Therapeutics AG as lead sponsor.

NCT NCT06208878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06208878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies
Lead sponsor
CRISPR Therapeutics AG
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 22, 2023
Completion date
August 31, 2038
Enrollment
70 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancy, solid malignancy